Trust Point’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Trust Point's AZN Position: Q3 2026 in Review
Trust Point increased its AstraZeneca (AZN) stake by 11% in Q3 2026, buying an estimated $23K and bringing the position to 1,376 shares worth $222K. The position accounts for 0.02% of the portfolio, ranked #466.
Trust Point first reported a position in AZN in Q2 2026 and has held it in 2 quarters since. The position peaked at $235K in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Trust Point held 1,376 shares of AstraZeneca worth $222K as of Q3 2026.
- Trust Point bought 138 AstraZeneca shares in Q3 2026, an estimated $23K.
- AstraZeneca made up 0.02% of Trust Point's portfolio in Q3 2026, its #466 holding.
- Trust Point first reported a position in AstraZeneca in Q2 2026 and has held it in 2 quarters since.
- Trust Point's AstraZeneca position peaked at $235K in Q2 2026.
- 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Trust Point's 13F filing for Q3 2026, filed 27 Oct 2026.